Companies: 10,795·Total market cap: $144.5T
Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

TERNNASDAQHealthcare
$52.95
$-0.02(-0.03%)
Market Cap$4.8B
P/E Ratio
52W High$53.19
52W Low$2.655
Overview

Terns Pharmaceuticals, Inc. (TERN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TERN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.03tern eps ttm · tern earnings per shareEarnings history
PE Ratio (TTM)tern pe ratio ttm · tern price to earningsPE Ratio deep dive
Revenue (TTM)0.00tern revenue ttm · tern annual revenueFull revenue history
Dividend YieldNo Dividenddoes tern pay dividends · tern dividend yieldDividend history
Shares Outstanding93.2Mtern shares outstanding · tern floatShares outstanding history
Next EarningsTBAtern earnings date · tern next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
terns pharmaceuticals, inc. revenue · tern revenue 2025
FY 2025Net Income-$96.2M▼ 8.28% YoY
202320242025
terns pharmaceuticals, inc. net income · tern profit 2025
FY 2025EPS$-1.03▲ +8.04% YoY
202320242025
tern eps · terns pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$96.2MEPS: $-1.03View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy16 analystsis tern a buy · tern analyst rating
Strong Buy
0
Buy
10
Hold
6
Sell
0
Strong Sell
0
12-Month Price Target
$53.00Low
$52.95Current
$58.13Avg Target9.78% upside
$70.00High
tern price target · tern 12 month forecast

Total: 16 · Buy rate: 62.5%

The TERN analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $58.13, representing +9.78% upside from the current price of $52.95.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+23.66%
YTD+31.06%
1Y+1327.22%
5Y+224.05%

About Terns Pharmaceuticals, Inc.

CEOAmy L. Burroughs
IPO DateFeb 5, 2021
Employees59
CountryUS

Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both s…

what is terns pharmaceuticals, inc. · tern stock overview · terns pharmaceuticals, inc. company profile · who is terns pharmaceuticals, inc. ceo · tern NASDAQ · terns pharmaceuticals, inc. headquarters · terns pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Terns Pharmaceuticals, Inc. (TERN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 5, 2021. As of the latest trading session, TERN stock price is $52.95, with a market capitalization of $4.8B. The stock has returned +1327.22% over the past 12 months and +31.06% year-to-date.

According to 16 Wall Street analysts, the consensus rating for Terns Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $58.13. In fiscal year 2025, Terns Pharmaceuticals, Inc. reported revenue of — and net income of -$96.2M. For detailed data — including Terns Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Terns Pharmaceuticals, Inc. (TERN) stock price is $52.95. The stock is traded on NASDAQ under the ticker symbol TERN. The 52-week range is $2.65 – $53.19.

TERN stock priceTERN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice